Position
Fidelity in Beam Therapeutics Inc.
Back to the book · All holders of BEAM
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $130.6M$23.83 → $34.32
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 11.9M | $330.1M | — | — | — | 0.0% |
| Q1 2026 | 12.5M | $296.7M | $23.83 | −$46.3M | $12.9M | 0.0% |
| Q2 2026 | 12.6M | $432.7M | $34.32 | $130.6M | $5.38M | 0.0% |